drugset / Trial / NCT01672333

Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma

NCT01672333 ↗

Phase 2 Completed 50 enrolled Milad Hospital
NaSingle-groupOpen-labelTreatment

Summary

Early stage diagnosis of gastric cancer has ensued different approaches in its resection strategies. In order to increase the proportion of cases that undergo radical resection and reduce the recurrence rate, different pre-operative treatments are introduced. Here, the investigators investigate an active preoperative chemotherapeutic regimen to in patients with locally advanced gastric cancer.

Timeline

Start
2008-06
Primary completion
2011-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 625 mg/m2 Oral
Subject Docetaxel Small molecule 50 mg/m2 Intravenous
Subject Oxaliplatin Small molecule 100 mg/m2 Intravenous